The formula used in the experiment consists of four herbs, called PHY906, and is based on a herbal recipe called Huang Qin Tang, used historically to treat nausea, vomiting and diarrhea. The study, published August 18 in the journal Science Translational Medicine, asked whether the use of the formula could reduce gastrointestinal effects of a common chemotherapy drug without affecting its ability to kill cancerous cells.
Chemotherapy causes a number of toxic side effects, which are usually treated with several different drugs with mixed success.
“Chemotherapy causes great distress for millions of patients, but PHY906 has multiple biologically active compounds which can act on multiple sources of discomfort,” said Yung-Chi “Tommy” Cheng, Henry Bronson professor of pharmacology, co-director of the Yale Cancer Center’s Developmental Therapeutics program and senior author of the paper.
Mice undergoing chemotherapy that were given PHY906 lost less weight and experienced more anti-tumor activity than mice not given the formula, the team reported.
The herbal formula reduced toxicity of the chemotherapy by multiple mechanisms, including the inhibiting inflammation and promoting the creation of new intestinal cells, the team reported. This cannot be accomplished by current drugs, which usually target only one mechanism.
“This combination of chemotherapy and herbs represents a marriage of Western and Eastern approaches to the treatment of cancer,” Cheng said.
Cheng is the co-discover of PHY906 and, with Yale, has a financial interest in PhytoCeutica Inc., a New Haven company developing the formula.
The study was funded by the National Cancer Institute of the National Institutes of Health.
Wing Lam of Yale was lead author of the paper. Other Yale authors include Scott Bussom, Fulan Guan, Zaoli Jiang, Wei Zhang, Elizabeth A. Gullen, Shwu-Huey Liu, Yung-Chi Cheng.
PRESS CONTACT: Bill Hathaway 203-432-1322